Search Results

Apply to the Career Development Program (CDP)

Supporting talented young physicians and scientists. Go directly to the information page on the CDP application process or browse our resources f…

Education Resources

37 Patient Organizations Applaud Proposed Rule to Rein in Short-Term Health Plans

health plans don’t offer typical health insurance benefits and don’t include consumer protections such as coverage for conditions, elimination of ann…

FDA Approves BiTE Therapy for Adults and Children with Leukemia Subtype

Blinatumomab has received full approval from the FDA after data confirmed its safety and efficacy.

Heath Ponder named as member of the National Philanthropy Committee

The Leukemia & Lymphoma Society (LLS) Georgia - South Carolina Region is pleased to announce the appointment of Heath Ponder, Director- Strategic Comm…

About Us

Latest FDA Approval Joins a Torrent of New Treatments for Aggressive Lymphoma Subtype

Rye Brook, N.Y., July , – The U.S. Food and Drug Administration (FDA) recently approved (Columvi™) to treat adults with diffuse large lymphoma (DLB…

News Release

The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category

News Release

Community Action Partnership

Community Action Agencies (CAA) are local organizations intended to promote , primarily funded through the federal government. Programs administered …

One Day To Remember

To create a fun and personalized activity or outing at no cost for the family to promote hope and provide the opportunity to create lasting, positive …

When Philanthropy and Competition Go Hand-in-Hand: Leaders Nationwide are Helping Blood Cancer Patients Survive and Thrive

When Philanthropy and Competition Go : Leaders Nationwide are Helping Blood Cancer Patients Survive and Thrive

Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL

BERKELEY, Calif., July , - Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading CRISPR biopharmaceutical company, today reported data from the dos…

Oracle Health Foundation

Oracle Health Foundation (formerly Cerner Charitable Foundation/First Hand Foundation) is building healthier tomorrows and stronger communities around…

Aberrant Megakaryopoiesis in the MPNs

A key feature of the MPNs is aberrant megakaryopoiesis, including increased numbers of megakaryocytes in essential thrombocythemia and atypical megak…

John Crispino

Dr. John Crispino is Chief of the Division of Experimental Hematology at St. Jude Children’s Research Hospital. He received his PhD from MIT for resea…

Gaurav Goyal

Dr. Goyal obtained his medical school diploma from Smt. N.H.L. Municipal Medical College in Ahmedabad, India, in and moved to the US to complete a re…